About MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
During the past decade, MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
2010-12-01
2013-12-01
Terminated
181
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
2011-03-01
2014-11-01
Completed
806
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
According to Clinical.Site data, the most researched conditions in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are
"Ischemic Stroke" (1 trials) and "Post Herpetic Neuralgia" (1 trials). Many other conditions were trialed in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" in a lesser frequency.
Clinical Trials Intervention Types at MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
Most popular intervention types in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "PF-03049423" (1 trials), "Placebo" (1 trials), "Pregabalin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
The vast majority of trials in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are
2 trials for "All" genders.
Clinical Trials Status at MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya
Currently, there are NaN active trials in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".